Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAINBOW-2a intracerebral autologous MSCs for chronic ischemic stroke
jRCT2013240055Phase 2Recruiting
- Sponsor
- RAINBOW
- Start
- Jan 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of HUNS001-01 in ischemic stroke, sponsored by RAINBOW. Primary endpoint: Improvement in modified Rankin Scale at 1 year. Started Jan 2025; status: recruiting.
02
Drugs
HUNS001-01
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2013240055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2013240055.